APA

Ning Y. M., Pierce W., Maher V. E., Karuri S., Tang S., Chiu H., Palmby T., Zirkelbach J. F., Marathe D., Mehrotra N., Liu Q., Ghosh D., Cottrell C. L., Leighton J., Sridhara R., Ibrahim A., Justice R. & Pazdur R. (20140721). Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summary. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Ning Yangmin M, Pierce William, Maher V Ellen, Karuri Stella, Tang Sheng-Hui, Chiu Haw-Jyh, Palmby Todd, Zirkelbach Jeanne Fourie, Marathe Dhananjay, Mehrotra Nitin, Liu Qi, Ghosh Debasis, Cottrell Christy L, Leighton John, Sridhara Rajeshwari, Ibrahim Amna, Justice Robert and Pazdur Richard. 20140721. Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summary. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Ning Y. M., Pierce W., Maher V. E., Karuri S., Tang S., Chiu H., Palmby T., Zirkelbach J. F., Marathe D., Mehrotra N., Liu Q., Ghosh D., Cottrell C. L., Leighton J., Sridhara R., Ibrahim A., Justice R. and Pazdur R. (20140721). Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summary. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Ning Yangmin M, Pierce William, Maher V Ellen, Karuri Stella, Tang Sheng-Hui, Chiu Haw-Jyh, Palmby Todd, Zirkelbach Jeanne Fourie, Marathe Dhananjay, Mehrotra Nitin, Liu Qi, Ghosh Debasis, Cottrell Christy L, Leighton John, Sridhara Rajeshwari, Ibrahim Amna, Justice Robert and Pazdur Richard. Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summary. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20140721.